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ABSTRACT 
Bisphenol A (BPA) is an organic compound with the chemical formula C15H16O2 and is made from phenol and acetone. It is a colorless solid that 
is soluble in organic solvents, but poorly soluble in water, having two phenol functional groups, it is used to make polycarbonate polymers and 
epoxy resins, along with other materials used to make plastics. Polycarbonate plastic is made by reacting BPA with phosgene. The 
mitochondrial toxicity was estimated by the assay of mitochondrial marker enzymes, by measuring the level of lipid peroxidation, GSH levels 
and levels of other antioxidant enzymes such as GPx, GR and SOD. Respiratory function of testicular mitochondria appears particularly 
susceptible to xenobiotic actions, which can contribute to a decrease in mitochondrial produced ATP and even to predispose cells to undergo 
mitochondria-mediated cell death. Our study showed that exposure to BPA induces significant oxidative stress in testicular mitochondria in 
mice and melatonin scavenges the free radicals. Human exposure to BPA is due to its widespread use, along with reproductive and 
developmental effects reported in animal study have generated considerable attention on this chemical in recent years. These aspects need 
further investigation in properly conducted studies with a wide dose range of BPA. 
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INTRODUCTION 
A challenge to the field of endocrine disruption is that these 
substances are diverse and may not appear to share any 
structural similarity other than usually being small 
molecular mass (<1000 Daltons) compounds. Thus, it is 
difficult to predict whether a compound may or may not 
exert endocrine-disrupting actions. Nevertheless, in very 
broad terms, EDCs such as dioxins, PCBs, PBBs, and 
pesticides often contain halogen group substitutions by 
chlorine and bromine. They often have a phenolic moiety 
that is thought to mimic natural steroid hormones and 
enable EDCs to interact with steroid hormone receptors as 
analogs or antagonists. Even heavy metals and metalloids 
may have estrogenic activity, suggesting that these 
compounds are EDCs as well as more generalized toxicants.  
Several classes of EDCs act as anti-androgens and as thyroid 
hormone receptor agonists or antagonists, and more 
recently, androgenic EDCs have been identified [1-4The 
sources of exposure to EDCs are diverse and vary widely 
around the world. The situation is constantly evolving 
because some EDCs were banned decades ago and others 
more recently, with significant differences between 
countries. In this respect, migrating people provide a model 
to study cessation and/or onset of exposure depending on 
contamination of the original and new milieus. There are also 
several historical examples of toxic spills or contamination 
from PCBs and dioxins that show a direct causal relationship 
between a chemical and the manifestation of an endocrine or 
reproductive dysfunction in humans and wildlife. However, 
these types of single exposures are not representative of 
more common widespread persistent exposure to a broad 
mix of indoor and outdoor chemicals and contaminants.  
Industrialized areas are typically characterized by 
contamination from a wide range of industrial chemicals that 
may leach into soil and groundwater [4-7]. These complex 
mixtures enter the food chain and accumulate in animals 
higher up the food chain such as humans, American bald 
eagles, polar bears, and other predatory animals. Exposure 
occurs through drinking contaminated water, breathing 
contaminated air, ingesting food, or contacting contaminated 
soil. People who work with pesticides, fungicides, and 
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industrial chemicals are at particularly high risk for exposure 
and thus for developing a reproductive or endocrine 
abnormality. 
Bisphenol A (BPA) is a key building block of polycarbonate 
plastic and a precursor for the manufacturing of monomers 
of epoxy resins. The BPA exposure of the general population 
is via food as a result of the use of BPA in food packaging and 
via skin as a result of contact with thermal paper. The vast 
majority of the population (91–99%) has detectable levels of 
BPA-conjugates in their urine. BPA is also present in medical 
devices including implants, catheters, tubing and some 
dental materials. This opinion describes the risk assessment 
of exposure to BPA via medical devices that are 
manufactured with materials that potentially leach BPA 
leading to oral (via dental material), subcutaneous and 
intravenous (e.g. during hemodialysis) routes of exposure. 
After oral exposure BPA is readily absorbed from the gastro-
intestinal tract and due to the first pass effect in the liver and 
the small intestine is rapidly conjugated to non-toxic 
metabolites.  
By the oral route BPA has a low systemic bioavailability (1-
10% in humans) and has a half life time of a few hours. For 
parenteral routes of exposure (intravenous, intraperitoneal, 
subcutaneous), BPA can be considered 100% systemically 
bioavailable. However, BPA will also be conjugated in the 
liver and the clearance of free BPA from the circulation 
appears to be relatively fast. Toxicity studies indicate that 
the kidney and the liver are relevant target organs for BPA 
toxicity. The lowest NOAEL after oral repeated exposure 
identified in several studies, including multigeneration 
reproductive toxicity studies, was approximately 5 mg/kg 
b.w./day. By applying the benchmark dose (BMD) approach, 
a BMDL10 of 8.96 mg/kg b.w./day was derived (EFSA 2015), 
based on the alteration in kidney weight. BPA is not likely to 
pose a genotoxic hazard to humans and has no carcinogenic 
activity, although there are some effects observed in the 
mammary gland, which currently are of unknown 
significance to human health [9-10]. Neither reproductive 
nor prenatal developmental toxicity are critical end-points in 
BPA toxicity, though BPA is associated with reproductive 
toxicity at doses higher than those causing liver and kidney 
damage. There are several indications that BPA might have 
biological effects below the recently determined BMDL10. 
However, the evidence is inconsistent, mainly obtained in 
dedicated studies focusing on different selected health 
effects and dose-response relationships could not be 
established. Regarding possible low dose effects, some 
concern remains for effects on mammary gland, metabolism 
and adiposity and neurobehavioral. 
Bisphenol A [Bis(4-hydroxyphenyl)propane] (BPA) is a high-
production volume industrial chemical, being a key building 
block of polycarbonate (PC) plastic and a precursor for the 
manufacturing of monomers of epoxy resins. Currently, 
many scientific discussions are ongoing on possible adverse 
effects of BPA. The general public is mostly exposed to BPA 
via food as a result of the use of BPA in food packaging and 
via skin as a result of contact with thermal paper. 
Polycarbonate is used in medical devices production (e.g. 
implants, catheters, tubing) for its balance of toughness, 
dimensional stability optical clarity, high heat resistance and 
electrical resistance. They may contain and release residual 
BPA during actual condition of use [10]. In addition to PC 
medical devices, various dental materials are fabricated from 
monomers such as bisphenol A glycidyl methacrylate (Bis-
GMA) and bisphenol A dimethacrylate (Bis-DMA), derived 
from BPA.  
BPA-resins are also used in inks and adhesives. In addition to 
BPA itself, polymers produced using BPA like polysulfone 
(PSU) used in medical devices (e.g. membrane in hemolysis 
dialyzers) are considered because they can release BPA. 
Some BPA-containing medical devices may have direct 
and/or indirect contact with patients (e.g. hemodialysis 
apparatus, filters, bypasses, tubing, pumps, instruments, 
surgical equipment, blood pathway circuits and respiratory 
tubing circuits). This Opinion describes the risk assessment 
of exposure to BPA via medical devices made up of materials 
potentially leaching BPA, for which the exposure routes are 
not limited to oral applications (i.e. for dental material) as 
exposure via other applications such as subcutaneous and 
intravenous (e.g. during hemodialysis) routes may occur [11-
12].  
Exposure from medical devices Medical devices based on PC 
and polysulfone due to their chemistry can contain BPA 
residues, whereas others like PVC-based medical devices 
may or may not contain BPA residues depending on their 
production method. In addition, some other BPA-derivatives 
(such as epoxy resins) are used specifically in dental 
materials. The major factor influencing the residual amount 
of BPA levels is the employment of incorrect operating. The 
safety of the use of bisphenol A in medical devices 10 
conditions during the processing step. Moreover, breakdown 
or hydrolysis of the PC polymer after manufacturing can 
occur, thus giving rise to the free monomer from the polymer 
available for exposure. In PC articles used for food contact, 
the residual content is usually less than 10 µg/g of PC. 
Exposure can be estimated by either measuring the BPA 
content of the medical devices or by extraction assays for 
potential release [13-14.  
For dental materials, the leakage is limited to resins 
composed of Bis-DMA (Bisphenol A dimethyl acrylate) which 
has an ester linkage that can be hydrolyzed to BPA, whereas 
the ether linkage in Bis-GMA (Bisphenol A glycidyl 
methacrylate) was found to be stable. Dental materials 
release BPA especially shortly (0- 1 h) after placement: the 
levels of BPA detected in saliva ranged from 0.64 ng/mL to 
30 μg/mL. This wide range in BPA measurements may 
indicate a continuous reduced leaching of BPA from dental 
materials, as well as reflect variations in the analytical 
methodology used. For BPA exposure resulting from the use 
of medical devices, little information is available. For the 
placing of dental composite resin restorations, 
measurements have shown that the release of BPA mainly 
occurs during the few hours directly after application while 
the BPA level is back to pretreatment levels at 24 hours. 
Values measured were up to 30 µg/mL saliva, and 931 µg in 
total saliva volume produced in one hour [15-16].  
Calculations based on the actual amount of material used in 
clinical practice and a median 4-year life-time of a composite 
restoration, suggest a maximum exposure of 0.06 µg 
BPA/day from fissure sealants, and a maximum exposure of 
0.36 µg BPA/day from composite restorations. Contact with 
dental materials gave an estimated acute (90%), but the 
systemic bioavailability of free BPA after oral exposure is 
reduced by the first pass effect. Based on the analysis of oral 
versus intravenous toxic kinetic data [17], the oral systemic 
bioavailability of unconjugated BPA is 2.8%, 0.2%,0.9% and 
less than 1% in rats, mice, monkeys, and dogs, respectively. 
The systemic availability of unconjugated BPA in humans has 
not been evaluated experimentally, however, modelled data 
as well as controlled biomonitoring studies indicated that 
internal exposure in humans to unconjugated BPA is very 
low (1-10%). The conjugates are readily excreted in urine; as 
a consequence the half-life of BPA in humans is very short, 
ranging from 1 to 3.5 h. After dermal exposure, the 
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absorption fraction can be considered approximately 25-
30% of the applied dose, which is directly systemically 
bioavailable [18].  
MATERIALS AND METHODS 
These include analysis procedures of biochemical 
estimations, mitochondrial enzyme estimations, and 
immunohistochemistry.  
Chemicals: 
Chemicals and other reagents used in this study were of high 
quality and purity grade available commercially. Some of the 
important chemicals are mentioned below. 
Bisphenol A, Benzyl amine, diaminobenzidine, Glutathione 
reduced (GSH), Glutathione reductase (GR), Glutathione 
oxidized (GSSG), Isocitrate, Lead citrate, Mannitol, Melatonin, 
Nicotinamide adenine dinucleotide reduced (NADH), 
Nicotinamide adenine dinucleotide phosphate (NADP), 
Nicotinamide adenine dinucleotide phosphate reduced 
(NADPH), Sodium succinate, Xanthine, Xanthine oxidase, 
Uranyl acetate,Copper sulphate, Cyclohexane, Cytochrome c, 
Diaminobenzidine, 2,6-Dicholorophenol indophenol, 
Disodium hydrogen phosphate, Ethyl acetate, Folin-Ciocalteu 
reagent (FCR), Formalin,  Gluteraldehyde, Magnesium 
chloride, Malonic acid, Nitroblue tetrazolium (NBT), 
Oxaloacetic acid, Paraformaldehyde, Potassium chloride, 
Sodium azide, Sodium phosphate, Sodium potassium 
tartarate, Sodium carbonate, Trichloroacetic acid (TCA), Tris 
HCl.Bovine serum albumin (BSA), epoxy resin araldite 
CY212, Ethylene diamine tetracetic acid (EDTA), HEPES 
Buffer, Potassium hydrogen phosphate, Potassium 
dihydrogen phosphate, Sodium chloride,  Sucrose, Tris 
Buffer, Dodecyl succinic anhydride, Osmium tetroxide, 
Sodium hydroxide (E. Merck. Germany). Thiobarbituric acid 
(TBA), tertiary butyl Hydroperoxide (Spectrochem Pvt. Ltd. 
Mumbai). Acetone, eosin, hematoxylin, hydrochloric acid, 
hydrogen peroxide, Metaphosphoric acid (HPO3), perchloric 
acid, paraffin, toluidine, xylene (S D Fine Chem Ltd. Mumbai). 
Ethyl alcohol, methanol, o-phthalaldehyde (Jiansu Huaxi 
International Trade Co. Ltd. China).DMP 30 (TAAB 
Laboratories Berks, UK). Anti-caspase 3 antibody (Biogenesis 
Inc. Poole, UK), anti- cytochrome c antibody (Santacruz  
Biotechnology  Inc. USA), anti-BCl2 antibody (Thermo Fisher 
Scientific, USA) and anti ER α antibody (Santacruz 
Biotechnology Inc. USA). Biotinylated antimouse IgG 
(Boehringer Mannheim, Germany), Streptavidin-peroxidase 
(Dako CA, USA).  
Animals: 
The study was conducted in male Swiss albino mice (25 ± 2 
g). The animals were maintained under the standard 
laboratory conditions (temperature 25 ± 2 ºC; photoperiod 
of 12 h). Commercial pellet diet and water were given ad 
libitum. 
Necropsy: 
After termination of treatment animals were sacrificed under 
mild anesthesia and their testes were taken out and washed 
with ice cold saline (0.9 % NaCl). After washing in ice cold 
isolation medium (0.25 M sucrose) and 1 mM EDTA (pH 7.4) 
testes were gently blotted between the folds of filter paper 
and weighed. 
Isolation of Mitochondria: 
All procedures were carried out on ice or at 4 ºC. Testes were 
minced in fresh isolation medium and gently homogenized 
manually (10 % w/v in isolation medium) using a 
homogenizer with a loose fitting pestle. The homogenate was 
centrifuged at 500 x g for 10 min. The supernatant fraction 
was retained and the pellet was washed with fresh isolation 
medium and recovered by the initial supernatant fraction. 
The pooled fractions were centrifuged at 500 x g for 10 min. 
The supernatant thus obtained was centrifuged at 5000 x g 
for 15 min to obtain the mitochondrial pellet. The pellet was 
washed first with isolation medium and then with 
respiration reaction buffer (70 mM sucrose, 220 mM 
mannitol, 2 mM HEPES, 0.5 mM EDTA, 2.5 mM MgCl2, 0.5 mM 
KH2PO4, 2 mM K2HPO4, (pH 7.4). The purifed mitochondria 
were obtained by centrifugation at 12,000 x g for 10 min. 
The final mitochondrial pellet was re-suspended in 
respiration reaction buffer (1 ml/g tissue) to produce a 
suspension containing 25-40 mg of mitochondrial pellet/ml. 
Mitochondria were isolated according to the method of 
Sayeed et al. [19]. 
Measurement of antioxidants: Enzymatic antioxidant 
Measurement of glutathione peroxidase (GPx) 
Freshly isolated mitochondria (0.1 ml) were suspended in 1 
ml of buffer (50 mM Tris HCl, 5 mM EDTA, 1 mM GSH, 0.22 
mM NADPH and 0.4 U GR (pH 7.6). Reaction was started by 
adding tertiary butyl hydroperoxide to a final concentration 
of 0.22 mM. The enzyme activity was calculated as nmol 
NADPH oxidized/min mg protein using molar extinction 
coefficient of 6.22 x 103 M−1 cm−1 [20-21] 
Measurement of glutathione reductase (GR) 
Assay mixture preheated to 25 °C prior to assay consisted of 
sodium phosphate buffer (0.2 M, p H- 7.6), containing 1 m M 
GSSG and 0.1 m M NADPH. An aliquot of 30 μl homogenizing 
buffer (250 mM sucrose, 80 mM Tris HCl, 5 mM MgCl2, 250 
mM KCl, 1 mM EDTA (pH 7.4) was dispensed in 6 wells of 96 
plate to determine background rate of reaction which was 
subtracted from enzymatic rate prior to calculation. Sample 
in aliquots of 20, 25 and 30μl were placed in triplicate in 
remaining wells. Homogenizing buffer was added to bring 
the volume in each well to 30 μl. Reaction was initiated by 
addition of 200μl of assay mixture per well.  Reading was 
taken at 2 min interval for 10 min. Plate returned to 
incubator between readings. The enzyme activity was 
quantitated as NADPH disappeared at 340 nm and calculated 
as nmol NADPH consumed/min mg protein using molar 
extinction coefficient of 6.22 x 103 M−1 cm−1. GR activity was 
measured by 96-well plate method of McFarland et al. [22]. 
Measurement of manganese Superoxide dismutase (Mn SOD)  
Manganese superoxide dismutase (Mn SOD) was measured 
by xanthine/xanthine oxidase mediated ferricytochrome c 
reduction method of Flohe and Otting [22]. Briefly, 
mitochondrial pellet (1 mg) suspended in (50 mM phosphate 
buffer and 0.1 mM EDTA, pH 7.8) and disrupted by 
sonication. Supernatant was collected after centrifugation 
and assayed for MnSOD activity. The assay mixture consisted 
of 50 μl sample in 2.9 ml reaction buffer (0.5 M xanthine, 0.1 
mM NaOH and 2M of cytochrome c in (50 mM phosphate 
buffer, 0.1 mM EDTA, pH 7.8). The reaction was initiated by 
adding 50 μl of xanthine oxidase (0.2 U/ml in 0.1 mM EDTA) 
and change in absorbance was monitored for 3 min at 438 
nm. The SOD activity was calculated as its ability to inhibit 50 
% reduction of ferricytochrome and expressed as U/min mg 
protein.  
Non-enzymatic antioxidant 
Measurement of reduced glutathione (GSH) 
Mitochondrial glutathione was estimated using the method 
of Hissin and Hilf [24]. Mitochondrial preparation (1 mg 
protein) was suspended in 25 μl of 25% HPO3 and 90 μl of 
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sodium phosphate buffer (0.1 M, pH 8.0, with 5 mM EDTA). 
The samples were centrifuged at 15,000 x g for 10 min at 4 
°C and the supernatant was collected for measurement of 
GSH. Supernatant (100 μl) was incubated with 100 μl of o-
phthalaldehyde (0.1% in methanol) and 1.8 ml of 0.1 M 
phosphate buffer (pH 8.0) for 15 min at room temperature in 
the dark. Fluorescence was measured with a fluorescence 
spectrophotometer (PerkinElmer, USA) at an excitation 
wavelength of 350 nm and an emission wavelength of 420 
nm. The GSH values are expressed as nmol/mg 
mitochondrial protein. 
Estimation of mitochondrial lipid peroxidation (LPO) 
LPO was measured by the method of Buege and Aust [25]. 
Mitochondrial preparation (0.5 ml) was mixed with equal 
volume of Buege and Aust reagent (TCA 15% w/v in 0.25 M 
HCl and TBA 0.37 % w/v in 0.25 M HCl) and heated for 15 
min in boiling water. After cooling the precipitate was 
removed by centrifugation at 1000 x g for 10 min at room 
temperature. Absorbance was measured at 532 nm. TBARS 
were quantified using an extinction coefficient of 1.56 X105 
M−1 cm−1 and expressed as nmol of TBARS/ mg protein.  
 
Experimental design 
                                               
Mice (n=3), orally for 14 
days 
Control (Corn oil only) 
BPA 5 mg/kg body weight 
BPA 10 mg/kg body 
weight 
BPA 100 mg/kg body 
weight 
 
BPA is a potent ligand of human estrogen-related receptor γ 
(ERRγ) with an EC50 value of 13.1 nM [26]. Although most 
studies have focused on the estrogenic effects of BPA, this 
compound also disrupts thyroid hormone action [27], acts as 
an AR antagonist and disrupts testosterone synthesis. BPA 
can be transferred to the fetuses from pregnant mice and 
alter postnatal development and sexual maturity. Perinatal 
or pubertal exposure of mice to BPA increases ERα and ERβ 
expression in the mouse forebrain and hypothalamus in rats 
[28].  BPA affects not only the receptors but also other 
cellular components such as plasma membrane, 
chromosomes etc amongst which mitochondria is of specific 
concern as complex I of the mitochondrial respiration chain 
is an important site of ROS [29].  
ROS such as superoxide anion, hydrogen peroxide and 
hydroxyl radical are generated in-vivo from the incomplete 
reaction of oxygen during aerobic metabolism or in 
stimulated host phagocytes, as well as from exposure to 
environmental agents such as redox cycling agents and 
radiations [30]. Oxidative stress occurs when the production 
of ROS exceeds the body’s natural antioxidant defense 
mechanisms causing damage to macromolecules such as 
DNA, proteins and lipids [31]. At low concentration ROS 
have been implicated in the regulation of several 
physiological processes such as proliferation, differentiation, 
apoptosis  and senescence. At high concentrations ROS are 
very toxic to cells and causes DNA damage, protein 
degradation and lipid peroxidation [32].  
To counteract the damaging effect of ROS, aerobic cells are 
provided with extensive antioxidant enzymes (e.g. 
superoxide dismutase, catalase, glutathione peroxidase etc) 
[33] and non-enzymatic antioxidants such as glutathione, 
vitamin E, vitamin C etc. EDC results in damage to the 
plasma membrane, disrupted mitochondrial membranes as 
well as nuclear membranes with ROS generation and altered 
Ca2+ homeostasis. The damage to mitochondria by EDCs not 
only leads to a pathophysiological condition but also leads to 
developmental toxicity in general. EDCs impair 
mitochondrial function in β-cells and induced remarkable 
swelling of mitochondria with loss of distinct cristae 
structure within the membrane, which was accompanied by 
disruption of mRNA expression of genes playing a key role in 
β-cell function (Glut2), (Slc2a2), Gck, Pdx1, Hnf1α, Rab27a, 
and Snap25) and mitochondrial function (Ucp2 and Ogdh) 
[34]. 
BPA caused a significant mitochondrial dysfunction 
including ROS production, mitochondrial membrane 
hyperpolarization, lipid accumulation, lipoperoxidation and 
the release of pro-inflammatory cytokines in hepatic cells 
triggered by disturbances in mitochondrial function, 
alterations in lipid metabolism and by inflammation [34]. 
With emerging data about the delirious effects of EDCs on 
mitochondria, it will be of worth to study the effects of BPA 
on the mitochondria in gonadal tissues. Doses were 
calculated and selected according to Tachibana et al., [36]. 
Table 1: Bispinol A and other control group. 
Number of Group                                                                     Dose and Control             
Group I Corn Oil (Control) 
Group II BPA (5 mg/kg body weight)  
Group III BPA (10 mg/kg body weight)  
Group IV BPA (100 mg/kg body weight)  
 
 
 LPO 
Enzymatic antioxidants: 
GPx, GR, SOD 
Non enzymatic 
antioxidants: 
GSH 
Isolation of 
mitochondria and 
estimation of 
enzymes 
Removal of 
testes 
Bisphenol A 
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RESULT AND DISCUSSION 
Results 
There are following effect on antioxidant enzymes as below. 
a) Glutathione Peroxidase (GPx): Group 1 (5 mg/kg body 
weight) of BPA shown significant decrease (P< 0.01) in GPx 
activity in the compare of Group 1 (Control group). Group II, 
BPA treated animal showed result as 21 % decrease in GPx 
activity in the compare of Group 1 (Control group). As likely 
Group III and Group IV BPA treated (10 mg/kg and 100 
mg/kg body weight respectively) obtained significant 
decrease (P< 0.01) in GPx activity in the compare of Group 1 
(Control group). Group III and Group IV (10 and 100 mg/kg 
body weight) BPA resulted in 27 % and 66 % decrease in 
GPx activity, respectively when compared with control 
animals (Table 2). 
b) Glutathione Reductase (GR): Group II in compare to 
Group 1 was observed a significant decrease (P< 0.05). 
Group III and Group III were resulted 19 % and 35% 
decrease in GR activity, respectively (P< 0.01) (Table 2).  
High dose of BPA (100 mg/kg body weight) caused about 65 
% decrease in activity of GR as compared with control group 
of animals.  
c) Superoxide Dismutase (SOD): The activity of SOD was 
decrease as the dose of BPA increased.  Decrease in activity 
of SOD in Group II and Group III was 34 % and 60 % as 
compared to control group of animals. Group IV (100 mg/kg 
body weight) treated with BPA caused a significant 76 % 
decrease in activity of SOD as compared to control group 
(Table 2).  
Lipid Peroxidation (LPO) 
The levels of LPO increased as the dose of BPA increased and 
testicular mitochondrial LPO levels were significantly (P< 
0.01) higher in BPA exposed groups as compared to Group 1 
(Control group). Lipid peroxidation increased about 51 % on 
treatment of Group 2 (5 mg/kg body weight) of BPA as 
compared with Group 1 (control group). Group III (10 
mg/kg body weight) BPA was caused significantly high 
about 113 % increase in LPO when compared with control 
group. Group IV (100 mg/kg body weight) of BPA caused 
LPO to increase almost 4 times over the controls.  
  
Table 2: Bispinol A effect on biochemical parameters of mitochondria. 
Groups          GPx        GR       SOD 
Group I 371.5 ± 17.015  
 
41.05 ± 3.79  
 
61.37 ± 4.11  
 
Group II 297.39 ± 4.024 
 
35.21 ±1.07 * 
 
31.17 ± 3.87 **  
 
Group III 255.13 ± 3.41** 
 
29.31 ± 1.89 
 
23.51 ±1.48 ** 
 
Group IV 131.25 ± 7.33  
 
15.01 ± 1.73 ** 
 
11.39 ± 1.01 ** 
 
Group I (Corn oil) is control, Group II (5 mg/kg body weight), Group III (10 mg/kg body weight), Group IV (100 mg/kg body 
weight). Values are expressed as Mean ± SE (n = 3). Significant is expressed as *P< 0.05 and **P< 0.01.  
 
DISCUSSION 
The general public is mostly exposed to BPA via food as a 
result of the use of BPA in food packaging and via skin as a 
result of contact with thermal paper. Polycarbonate is used 
in medical devices production (e.g. implants, catheters, 
tubing) for its balance of toughness, dimensional stability 
optical clarity, high heat resistance and electrical resistance. 
They may contain and release residual BPA during actual 
condition of use. In addition to PC medical devices, various 
dental materials are fabricated from monomers such as 
bisphenol A glycidyl methacrylate (Bis-GMA) and bisphenol 
A dimethacrylate (Bis-DMA), derived from BPA. BPA-resins 
are also used in inks and adhesives. In addition to BPA itself, 
polymers produced using BPA like polysulfone (PSU) used in 
medical devices (e.g. membrane in hemolysis dialyzers) are 
considered because they can release BPA. Some BPA-
containing medical devices may have direct and/or indirect 
contact with patients (e.g. hemodialyzer apparatus, filters, 
by passes, tubing, pumps, instruments, surgical equipment, 
blood pathway circuits and respiratory tubing circuits). BPA 
is an endocrine-disrupting chemical which is continuously 
released into the environment because of its extensive usage 
as plasticizer and other industrial applications. BPA radical, 
are formed by a reaction of radical oxygen [37-38].  
Atkinson and Roy, have reported that BPA is oxidized to a 
reactive metabolite 4,5-bisphenol- O-quinone which forms 
DNA adduct in rat liver DNA in the presence of peroxidase 
activation [39]. Oxidative stress in any tissue results from an 
imbalance between the production of (ROS) and their 
efficient removal by available antioxidant systems. ROS are 
small, oxygen-based molecules that are highly reactive 
because of unpaired electrons [40]. The predominant source 
of free radical generation is the mitochondrial respiratory 
chain and inhibition of this process is often connected to 
increased levels of free radicals [41]. These ROS result in 
increased lipid peroxidation and modulation of intracellular 
oxidized states, DNA damage, membrane damage, altered 
gene expression and apoptosis.  
Bisphenol A (BPA) is a key building block of polycarbonate 
plastic and a precursor for the manufacturing of monomers 
of epoxy resins. The BPA exposure of the general population 
is via food as a result of the use of BPA in food packaging and 
via skin as a result ofcontact with thermal paper. The vast 
majority of the population (91–99%) has detectable levels of 
BPA-conjugates in their urine. BPA is also present in medical 
devices including implants, catheters, tubing, and some 
dental materials. This Opinion describes the risk assessment 
of exposure to BPA via medical devices that are 
manufactured with materials that potentially leach BPA 
leading to oral (via dental material), subcutaneous and 
intravenous (e.g. during haemodialysis) routes of exposure. 
By the oral route BPA has a low systemic bioavailability (1-
10% in humans) and has a half life time of a few hours. For 
parenteral routes of exposure (intravenous, intraperitoneal, 
subcutaneous), BPA can be considered 100% systemically 
bioavailable. 
Toxicity studies indicate that the kidney and the liver are 
relevant target organs for BPA toxicity. The lowest NOAEL 
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after oral repeated exposure identified in several studies, 
including multigeneration reproductive toxicity studies, was 
approximately 5 mg/kg b.w./day. By applying the 
benchmark dose (BMD) approach, a BMDL10 of 8.96 
mg/kgb.w./day was derived, based on the alteration in 
kidney weight. BPA is not likely to pose a genotoxic hazard 
to humans and has no carcinogenic activity, although there 
are some effects observed in the mammary gland, which 
currently are of unknown significance to human health. 
Neither reproductive nor prenatal developmental toxicity 
are critical end-points in BPA toxicity, though BPA is 
associated with reproductive toxicity at doses higher than 
those causing liver and kidney damage. BPA administered 
orally to mice induced LPO and decreased various vital 
antioxidant enzymes such as SOD, GPx, GR and non-
enzymatic antioxidant such as GSH in testicular 
mitochondria.  
This suggests increase production of reactive oxygen species 
(ROS) in mitochondria of exposed group. In most of the in-
vivo toxicity studies in mammals oral route of administration 
of BPA has been employed, as it is the main route of 
exposure in human [42]. BPA induced discernible oxidative 
stress response in mice. It is now recognized that the 
oxidative damage is the primary cause of sub-cellular effects 
of different classes of EDCs [43]. LPO is caused by the action 
of ROS. ROS also cause damage to DNA and proteins 
resulting in various harmful consequences have reported 
that BPA induced LPO in rats and role of mitochondria in 
testicular apoptosis [42]. 
LPO induction was found to be dose-dependent. GSH either 
alone or in conjugation with other proteins, can protect cells 
against LPO [43]. Mitochondrial GSH plays a critical role in 
maintaining cell viability through the regulation of 
mitochondrial inner membrane permeability by maintaining 
sulfhydryl groups in reduced state [46].  
However, in our study when the relative responses of LPO 
and GSH were compared effect of BPA was more pronounced 
in case of LPO induction than decrease in GSH. Moon et al., 
using mice model have shown that BPA (0.05 mg/kg body 
weight and 1.2 mg/kg body weight for 5 days i.p) led to 
increase in LPO in liver mitochondria in mice [47]. On the 
pattern of our observations, they also found that the 
oxidative stress and LPO occurs in mitochondria. Hassan et 
al., have also reported on LPO inducing effect of BPA in liver 
and decrease in activities of SOD, GPx and GR in liver in rat. 
Antioxidants are located throughout the cell and provide 
protection against ROS toxicity [48]. The lower activity of 
SOD in BPA exposed group may be explained by the 
inhibition of SOD by its product hydrogen peroxide or by 
hydroxyl radical. Our study also shows a dose dependent 
decrease in activities of GR, GPx, and SOD in the testicular 
mitochondria of mice. Decrease in the GSH level and 
disruption of activities of antioxidant enzymes as reported 
here might contribute to histological changes. 
Findings of the present study suggest a role for free radicals, 
especially ROS and disruption of antioxidants in BPA 
induced toxicity in testicular mitochondria of mice. Oxidative 
stress can induce mitochondrial damage and damaged 
mitochondria can generate more ROS. Mitochondria are 
vulnerable to ROS due to impairment of the antioxidant and 
DNA repair enzyme systems [49]. Accumulation of oxidative 
damage in the mitochondria induces mitochondrial 
dysfunction, mitochondrial DNA depletion and cell apoptosis 
[48]. Deleterious effect of BPA includes its oxidative stress 
causing property, which generates highly reactive 
membrane toxic intermediates in liver, kidney, testes and 
brain of rats. BPA has been shown to induce ROS generation 
in the epididymal sperm of rats. BPA exposure causes 
enzyme inactivation by excess ROS production in 
mitochondria and microsomes [51]. In a tissue like the testis, 
with its high rates of metabolism and cell replication, 
oxidative stress can be especially damaging, which makes 
the antioxidant capacity of the tissue very important. ROS 
have been shown to play an important role in the defense 
mechanisms against pathological conditions but excessive 
generation of free oxygen radicals may damage tissues.  
BPA is a known endocrine disruptor and studies have 
suggested that it causes developmental and reproductive 
toxicity. Endocrine disrupting chemicals cause adverse 
effects in target organs by interfering with the interaction of 
endogenous hormones and their receptors. Environmental 
estrogens can mimic the natural estrogen, 17 b-estradiol 
(E2) and disrupt the endocrine system of aquatic animals 
[52].The reproductive toxicity is caused by interaction with 
androgen and estrogen receptors [53]. Most developmental 
effects of estrogens are mediated by their binding to an 
intracellular steroid receptor protein, either ERα or ERβ. 
BPA also compete for 17β-E2 to ERβ and its binding to ERs 
results in changes in expression of related genes [54].  
The present result of the study establishes oxidative stress 
inducing effects of BPA in testicular mitochondria of Swiss 
albino mice. The present study focuses on the light 
microscopic and ultra-structural changes in the adult mice 
after treatment with BPA as compared with control group. In 
present study we are going to discuss the effects of BPA on 
testicular tissue in general and mitochondria in specific. 
Light microscopic observations showed that low doses of 
BPA (5 and 10 mg/kg body weight) exposure for 14 days 
caused reduction in the number of cells in the layers of 
seminiferous tubules. This reduction may be due to the 
apoptosis of cells by BPA treatment [55]. Highest dose of 
BPA treatment for 14 days caused much damage to the 
seminiferous tubules and the tubule (Fig. 1H) is in the 
spermatogenetic cycle. Portions of the tubule show 
disappearance of cells and prominent vacuolar change. This 
shows that a lot of cells turned apoptotic.  
There were many ultra-structural changes found in the 
treated groups as compared to the control group. Studies 
suggest that BPA exposure causes ultrastructural changes in 
testis of rodents [54-55]. Basement membrane is the 
membrane covering the seminiferous tubules of the testes. 
BPA treatment caused membrane damage of the 
seminiferous tubules. Membranes are made up of lipids and 
BPA causes LPO in the membranes. The damage increased as 
the dose of BPA increased.  Another significant change which 
was observed was the detachment of the basal cells. 
The decrease in number of spermatogenic cells shows that 
apoptosis may have occurred and cells might have died. 
Destruction of the spermatogonial complement of the testis 
results in sterility. Also vacuolization was observed in these 
cells. Study has also confirmed that BPA caused apoptosis in 
testicular cells. Spermatocyte and spermatogonia were 
affected by BPA treatment in our study.  A study showed that 
low concentration of BPA caused spermatogenic and Sertoli 
cells to apoptosis, whereas a higher concentration tend to 
lead spermatogenic and Sertoli cells to necrosis in goat [58].  
Apoptotic spermatogonia were characterized by a ruptured 
nucleus, shrinkage of the cytoplasm and nucleus, and still 
functioning cell organelles. Mitochondria are target of BPA 
and it causes mitochondrial membrane permeability 
transition has been shown by Kashiwagi et al., [57]. These 
ROS could also cause apoptosis of the Sertoli and 
spermatogenic cells in the seminiferous tubules of the 
testicular tissue. A study has shown that BPA and some 
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related phenols are cytotoxic, most likely through the 
impairment of mitochondrial function and consequent 
decrease in the cellular level of ATP [60]. Also compound 
bisphenol A diglycidyl ether-induced apoptosis involves 
Bax/Bid dependent mitochondrial release of apoptosis-
inducing factor (AIF), cytochrome c and Smac/DIABLO. 
Cristae of mitochondria were absent in many mitochondria 
of Sertoli cell in animals treated with BPA (Fig. 3N). This may 
be due to oxidative stress, Ca2+ overload, and ATP loss 
perhaps due to Bax-mediated effects and this shows 
mitochondria mediated apoptosis [61] 
BPA negatively affected male germ cell number and hence 
may affect fertility. BPA causes release of ROS and oxidative 
stress in mitochondria of testes. These free radicals 
generated are having the potential to adversely affect the 
germ cell and is components. There are evidences that ROS 
can induce apoptosis via several mechanisms, including 
mitochondria-dependent or independent pathway in various 
cell lines and tissues [62]. Mitochondria provide the gateway 
through which apoptosis can be executed in a rapid and 
robust manner. BPA affected activities of vital enzymes of 
mitochondria which are part of mitochondrial bioenergetics 
as well as reduced glutathione levels. Ultra-structurally BPA 
causes apoptosis of spermatogenic cells in the testes.  
Apoptosis caused by BPA may be manifested as a result of 
release of ROS in the testicular tissue, which is also inferred 
by the reduced levels of GSH. At molecular level BPA 
interferes with the development process of sperm by 
interacting with the estrogen receptors. BPA affected 
different type of cells in various stages of sperm 
development in the seminiferous tubules. It affected 
spermatogonia, spermatocyte, sertoli cell and developing 
spermatids.  Infertility is a major problem now a days and by 
the results received by us we can infer that environmental 
endocrine chemical BPA is a potent endocrine disruptor and 
has potential to cause testicular toxicity. Human exposure to 
low level of BPA is continuous and BPA can bioaccumulate in 
some conditions, there is concern about human reproductive 
health especially for occupational workers exposed to higher 
levels of BPA.  The result shown that BPA exposure causes 
testicular toxicity and histopathological alterations in the 
testes of mice. BPA induced alterations in mitochondria and 
causes germ cell apoptosis as seen by decrease number of 
cells in BPA exposed groups.  
CONCLUSION 
Human exposure to BPA is due to its widespread use, along 
with reproductive and developmental effects reported in 
animal studies have generated considerable attention on this 
chemical in recent years. Our study suggests that BPA 
induces toxicity in mitochondria and upsets the antioxidant 
status of the mitochondria. Also it causes apoptosis as 
determined by the expression pattern of proteins involved in 
apoptosis cascade. These findings suggest that BPA may 
cause testicular toxicity by impacting various testicular cell 
types and by activating the mitochondrial apoptotic 
pathway. Our study showed that exposure to BPA induces 
significant oxidative stress in testicular mitochondria in 
mice and melatonin scavenges the free radicals. These 
aspects need further investigation in properly conducted 
studies with a wide dose range of BPA. 
In the present investigation the decrease in enzyme activity 
in exposed groups could be attributed to ROS production. 
Small inefficiencies in the mitochondrial ETC produce 
background levels of ROS that can lead to severe 
mitochondrial dysfunction and cell death. In mitochondria 
oxidative stress is caused when the balance between 
antioxidant enzymes such as GPx, GR and SOD and most 
importantly of GSH goes down. When GSH levels are greatly 
decreased, H2O2 accumulates, and this leads to extensive 
mitochondrial damage. Other antioxidants may be involved 
in the protection of mitochondria. Mitochondrial GSH 
homeostasis is essential to ensure the protection against the 
oxidative damage of mitochondria and thus of the whole cell. 
Oxidative stress in mitochondria may lead to mitochondrial 
dysfunction and can affect bioenergetics processes. 
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